Study co-author Davey Daniel reviews the findings of the phase III PACIFIC trial investigating durvalumab in patients with locally advanced, unresectable NSCLC.
25-09-2017 | Non-small-cell lung cancer | ESMO 2017 | Video
25-09-2017 | Non-small-cell lung cancer | ESMO 2017 | Video
Study co-author Davey Daniel reviews the findings of the phase III PACIFIC trial investigating durvalumab in patients with locally advanced, unresectable NSCLC.